Stephen David Ryder
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 122
- Hepatitis C virus research 60
- Liver Disease and Transplantation 42
- Liver Diseases and Immunity 22
- Epidemiology 97
- Liver Disease Diagnosis and Treatment 79
- Hepatitis B Virus Studies 31
- Co-authors
- Peter D James (2 shared papers)Guruprasad Padur Aithal (19 shared papers)William Lucien Irving (16 shared papers)S. A. C. Hawkins (7 shared papers)Adam Lawson (3 shared papers)Mark R. Thursz (10 shared papers)Philip Kaye (3 shared papers)Jonathan Michael Rhodes (8 shared papers)
- Journals
- Journal of Hepatology (28 papers)Journal of Viral Hepatitis (13 papers)Gastroenterology (11 papers)Alimentary Pharmacology & Therapeutics (11 papers)Gut (8 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Stephen David Ryder
236 papers receiving 13.2k citations
Stephen David Ryder's Hit Papers
Peers
Comparison fields: 5 of 165
- Hepatology 6.9k
- Epidemiology 6.0k
- Neurology 724
- Endocrinology, Diabetes and Metabolism 833
- Pathology and Forensic Medicine 868
Countries citing papers authored by Stephen David Ryder
This map shows the geographic impact of Stephen David Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen David Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen David Ryder more than expected).
Fields of papers citing papers by Stephen David Ryder
This network shows the impact of papers produced by Stephen David Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen David Ryder. The network helps show where Stephen David Ryder may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen David Ryder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Hit paper breakdown → | 2016 | 1652 |
| 2 | Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis Hit paper breakdown → | 2008 | 604 |
| 3 | Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis Hit paper breakdown → | 2014 | 481 |
| 4 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Hit paper breakdown → | 2022 | 479 |
| 5 | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm Hit paper breakdown → | 2014 | 415 |
| 6 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Hit paper breakdown → | 2020 | 404 |
| 7 | The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology Hit paper breakdown → | 2020 | 363 |
| 8 | 2003 | 344 | |
| 9 | 1995 | 307 | |
| 10 | 2004 | 265 | |
| 11 | A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis Hit paper breakdown → | 2021 | 241 |
| 12 | 2004 | 234 | |
| 13 | 2001 | 231 | |
| 14 | 2020 | 229 | |
| 15 | 2015 | 220 | |
| 16 | 2014 | 211 | |
| 17 | 2014 | 166 | |
| 18 | 2016 | 163 | |
| 19 | 2000 | 158 | |
| 20 | 2002 | 155 |
About Stephen David Ryder
Stephen David Ryder is a scholar working on Hepatology, Epidemiology, Neurology, Pathology and Forensic Medicine and Surgery, having authored 243 papers that have together received 13.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (79 papers), Hepatitis C virus research (60 papers), Liver Disease and Transplantation (42 papers), Hepatitis B Virus Studies (31 papers), Liver Diseases and Immunity (22 papers), Prion Diseases and Protein Misfolding (21 papers), Alcohol Consumption and Health Effects (18 papers) and Neurological diseases and metabolism (15 papers). The work is most often cited by research in Hepatology (6.9k citations), Epidemiology (6.0k citations), Neurology (724 citations), Endocrinology, Diabetes and Metabolism (833 citations) and Pathology and Forensic Medicine (868 citations). Stephen David Ryder has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Peter D James, Guruprasad Padur Aithal, William Lucien Irving, S. A. C. Hawkins, Adam Lawson, Mark R. Thursz, Philip Kaye, Jonathan Michael Rhodes, Thierry Baron and Jean Laplanche. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Gastroenterology, Alimentary Pharmacology & Therapeutics and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.